The Globe and Mail reports in its Thursday, Jan. 29, edition that National Bank Financial analyst Vishal Shreedhar has reaffirmed his "outperform" recommendation for Loblaw. The Globe's David Leeder writes that Mr. Shreedhar bumped his share target ahead by $4 to $66. Analysts on average target the shares at $66.46. Mr. Shreedhar predicts that Loblaw will experience relatively consistent performance. He says an extra week of results will lead to strong earnings-per-share growth in its 2025 fourth quarter. Mr. Shreedhar says in a note: "Intensifying competitive intensity due to sq. ft. growth is a concern; however, our analysis suggests that competitive pressure remains manageable, for now (margins remain healthy). ... We maintain a favourable view on Loblaw and recommend it as our preferred grocer supported by: (I) Benefits from improvement initiatives; (ii) Ongoing stable EPS growth; and (iii) Favourable medium-term trends in discount and drug store (where Loblaw over-indexes). Given an uncertain macro backdrop, we favour proven staples such as Loblaw to add resiliency to portfolios." The Globe reported on Oct. 23 that Mr. Shreedhar had reaffirmed his "outperform" call for Loblaw. It was then worth $58.48.